Log in
Enquire now
‌

US Patent 7276347 Cytoxan antibodies and immunoassay

Patent 7276347 was granted and assigned to Saladax Biomedical on October, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Saladax Biomedical
Saladax Biomedical
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
72763470
Patent Inventor Names
Salvatore J. Salamone0
Jodi Blake Courtney0
Dennis Stocker0
Date of Patent
October 2, 2007
0
Patent Application Number
111853610
Date Filed
July 20, 2005
0
Patent Citations Received
‌
US Patent 11860173 Hazardous contaminant collection device with integrated swab and test device
0
‌
US Patent 11782042 Hazardous contaminant collection kit and rapid testing
Patent Primary Examiner
‌
Long V. Le
0
Patent abstract

Novel conjugates of protected aldehyde active metabolites of cyclophosphamide including reagents and immunogens thereof and monoclonal antibodies generated by these immunogens, said reagents and immunogens useful in immunoassays for the monitoring of the active metabolites of cyclophosphamide in patients being treated with cyclophosphamide.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7276347 Cytoxan antibodies and immunoassay

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.